Chugai Pharmaceutical Co....

OTC: CHGCY · Real-Time Price · USD
21.23
0.44 (2.12%)
At close: Aug 15, 2025, 2:14 PM

Chugai Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
540.2B 458.67B 222.17B 267.75B
Short-Term Investments
456.14B 280.31B 280.94B 204.22B
Long-Term Investments
n/a 61.09B -279.1B -201.82B
Other Long-Term Assets
73.07B 64.47B 335.29B 246.49B
Receivables
334.26B 318.89B 512.54B 355.08B
Inventory
240.07B 273.48B 292.21B 208.84B
Other Current Assets
35.38B 13.24B 9.92B 10.47B
Total Current Assets
1,606B 1,366.4B 1,336.5B 1,063.7B
Property-Plant & Equipment
441.55B 420.7B 386.65B 352.11B
Goodwill & Intangibles
17.87B 19.86B 25.14B 21.97B
Total Long-Term Assets
602.33B 566.12B 533.22B 475.03B
Total Assets
2,208.4B 1,932.5B 1,869.8B 1,538.7B
Account Payables
65.35B 112.47B 209.84B 152.27B
Deferred Revenue
n/a n/a 79M 86M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
116.27B 131.12B 176.06B 140.65B
Total Current Liabilities
290.36B 288.22B 423.73B 327.42B
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
11.44B 18.37B 21.64B 23.25B
Total Long-Term Liabilities
16.52B 18.75B 21.64B 23.25B
Total Liabilities
306.87B 306.97B 445.37B 350.68B
Total Debt
n/a 13.46B 14.11B 16.04B
Common Stock
n/a n/a 73.2B 73.2B
Retained Earnings
n/a 1,488.7B 1,293.4B 1,054B
Comprehensive Income
n/a -5.71B -10.97B -7.46B
Shareholders Equity
1,901.5B 1,625.6B 1,424.4B 1,188B
Total Investments
456.14B 280.31B 1.84B 2.39B